Inventiva (IVA) Exchange Rate Effect (2021 - 2022)
Inventiva (IVA) recorded quarterly Exchange Rate Effect of $2.4 million in Q4 2022, up 171.16% quarter-over-quarter from -$3.4 million in Q3 2022, and down 28.16% on a YoY basis from $3.4 million in Q4 2021.
Inventiva (IVA) Exchange Rate Effect (2021 - 2022) Analysis & Trends
Inventiva's Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $2.4 million for Q4 2022.
- In Q4 2022, Exchange Rate Effect fell 28.16% year-over-year to $2.4 million; the TTM figure through Dec 2022 stood at $10.4 million (changed N/A YoY), while the FY2025 annual figure was -$544772.4, down 141.21% from the prior year.
- Exchange Rate Effect was $2.4 million for Q4 2022 at Inventiva, up from -$3.4 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $8.0 million in Q2 2021 to a low of -$4.4 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 8.68 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.44 Mn |
| Dec 31, 2022 | 2.44 Mn |
| Sep 22, 2022 | -3.43 Mn |
| Sep 22, 2022 | -3.43 Mn |
| Dec 31, 2021 | 3.39 Mn |
| Dec 31, 2021 | 3.39 Mn |
| Jun 30, 2021 | 7.99 Mn |
| Jun 30, 2021 | 7.99 Mn |
| Mar 31, 2021 | -4.42 Mn |
| Mar 31, 2021 | -4.42 Mn |